Showing results (2041-2050 of 3,641) with videos related to
Sort By:
Pageof 365
Breast (Edinburgh, Scotland)|February 19, 2019
Non-pharmacological therapies for depressive symptoms in breast cancer patients: Systematic review and meta-analysis of randomized clinical trialsLiliana Coutiño-Escamilla, Maricela Piña-Pozas, Aurelio Tobías Garces, et al.Breast (Edinburgh, Scotland)|December 21, 2021
Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancerSibylle Loibl, Jenny FurlanettoBreast (Edinburgh, Scotland)|December 21, 2021
Locally advanced breast cancerStefan Aebi, Per Karlsson, Irene L WapnirBreast (Edinburgh, Scotland)|December 20, 2021
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort studyDelal Akdeniz, Mark van Barele, Bernadette A M Heemskerk-Gerritsen, et al.Breast (Edinburgh, Scotland)|November 4, 2021
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspectiveMarie Forster, Rachel Wuerstlein, Alexander Koenig, et al.Breast (Edinburgh, Scotland)|December 19, 2021
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysisHee Jeong Kim, Seonok Kim, Rachel A Freedman, et al.Breast (Edinburgh, Scotland)|July 28, 2019
Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based studyXingxi Pan, Wen Yang, Yongfa Chen, et al.Breast (Edinburgh, Scotland)|March 19, 2019
Towards mm-wave spectroscopy for dielectric characterization of breast surgical marginsPaul E Summers, Andrea Vingiani, Salvatore Di Pietro, et al.Breast (Edinburgh, Scotland)|March 12, 2014
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off valuesGábor Cserni, András Vörös, Inta Liepniece-Karele, et al.Breast (Edinburgh, Scotland)|April 29, 2014
Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapyIvana Bozovic-Spasojevic, Lieveke Ameye, Marianne Paesmans, et al.Pageof 365